TrialBreast (Edinburgh, Scotland)2026

Dose-dense adjuvant chemotherapy in HER2-low breast cancer: An exploratory analysis of the GIM2 trial.

Chiara Molinelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.